Literature DB >> 3081175

Guidelines to control heparin treatment.

A G Fennerty, S Renowden, N Scolding, D P Bentley, I A Campbell, P A Routledge.   

Abstract

With new guidelines for the control of heparin infusion rates the proportion of kaolin cephalin clotting time ratios was significantly improved compared with ratios achieved without their use. Further improvement might result from careful preparation and delivery of the infusion.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3081175      PMCID： PMC1339561          DOI： 10.1136/bmj.292.6520.579

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


  4 in total

1.  A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time.

Authors:  D Basu; A Gallus; J Hirsh; J Cade
Journal:  N Engl J Med       Date:  1972-08-17       Impact factor: 91.245

2.  Intersubject variability in the anticoagulant response to heparin in vitro.

Authors:  T D Bjornsson; K M Wolfram
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  Circadian changes in anticoagulant effect of heparin infused at a constant rate.

Authors:  H A Decousus; M Croze; F A Levi; J G Jaubert; B M Perpoint; J F De Bonadona; A Reinberg; P M Queneau
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-02

4.  Heparin kinetics in venous thrombosis and pulmonary embolism.

Authors:  J Hirsh; W G van Aken; A S Gallus; C T Dollery; J F Cade; W L Yung
Journal:  Circulation       Date:  1976-04       Impact factor: 29.690
  4 in total
  7 in total

Review 1.  The Smith Kline & French lecture 1987. Clinical pharmacology and the art of bespoke prescribing.

Authors:  P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

2.  Symptomatic intracerebral hematomas in posterior circulation stroke patients anticoagulated with heparin.

Authors:  Kyusik Kang; Byung-Woo Yoon
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

Review 3.  Anticoagulants in venous thromboembolism.

Authors:  A Fennerty; I A Campbell; P A Routledge
Journal:  BMJ       Date:  1988-11-19

4.  Fatal pulmonary embolus in a patient treated with Marvelon.

Authors:  N J Scolding; O M Gibby
Journal:  J R Coll Gen Pract       Date:  1988-12

Review 5.  Intravenous heparin dosing: patterns and variations in internists' practices.

Authors:  B M Reilly; R Raschke; S Srinivas; T Nieman
Journal:  J Gen Intern Med       Date:  1993-10       Impact factor: 5.128

Review 6.  Pharmacokinetic optimisation of the treatment of deep vein thrombosis.

Authors:  A Iorio; G Agnelli
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

Review 7.  Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy.

Authors:  H G Shetty; A G Fennerty; P A Routledge
Journal:  Clin Pharmacokinet       Date:  1989-04       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.